InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.88
(
0.18%
)
US TECH 100
19,209.20
(
-0.03%
)
Dow Jones
39,096.24
(
-0.08%
)
Brent Oil
85.16
(
0.81%
)
Bitcoin
61,764.75
(
1.57%
)
Post# of 252398
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119931
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 180525

Wednesday, 08/13/2014 4:43:44 PM

Wednesday, August 13, 2014 4:43:44 PM

Post# of 252398
AGN makes small acquisition:

http://finance.yahoo.com/news/allergan-acquires-liris-program-taris-203000289.html

Allergan Inc. and TARIS Holdings LLC today announced that Allergan has closed a transaction to acquire worldwide rights to TARIS Biomedical’s lead program, LiRIS, which is currently in Phase 2 trials for the treatment of interstitial cystitis / bladder pain syndrome.

Allergan paid $67.5 million in cash upfront, subject to certain adjustments and holdbacks. Allergan has also agreed to pay up to an aggregate of $295 million in development milestone payments and up to an aggregate of $225 million in commercial milestone payments.

It will take more than this for AGN to fend off the hostile offer from VRX.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up